• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌大小:血小板、γ-谷氨酰转肽酶和碱性磷酸酶。

Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.

机构信息

Department of Nutritional Carcinogenesis, IRCCS S. de Bellis National Institute for Digestive Diseases, Castellana Grotte, Italy.

出版信息

Oncology. 2013;85(3):153-9. doi: 10.1159/000354416. Epub 2013 Aug 29.

DOI:10.1159/000354416
PMID:23988857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3863783/
Abstract

BACKGROUND

Thrombocytopenia is a cirrhosis surrogate which is associated with hepatocellular carcinoma (HCC) development.

AIMS

To compare the clinical characteristics of HCC in the presence and absence of thrombocytopenia.

METHODS

The baseline clinical data of a large cohort of randomly presenting, biopsy-proven HCC patients was examined for phenotypic patterns, after organizing the data by tumor size and subdivision into tumor size terciles.

RESULTS

Small tumor size tercile I patients had the lowest platelet counts. Patients with higher platelets within each size tercile had the lowest bilirubin and prothrombin time and higher γ-glutamyl transpeptidase (GGTP) and alkaline phosphatase (ALKP) levels. When patients with similar platelet and bilirubin levels were compared, α-fetoprotein, GGTP, and ALKP were significantly increased in patients with larger tumors and in the presence of portal vein thrombus. Large tumor size tercile III patients without thrombocytopenia had larger tumors, higher GGTP and ALKP, and lower bilirubin levels than did patients with thrombocytopenia.

CONCLUSIONS

Thrombocytopenia occurred in 40.7% of patients with smaller tumors but only in 11.3% of patients with larger tumors. Patients without thrombocytopenia had elevated GGTP and ALKP and lower bilirubin levels, regardless of tumor size, but they also had larger tumors within the large tumor tercile.

摘要

背景

血小板减少症是肝硬化的替代指标,与肝细胞癌(HCC)的发展相关。

目的

比较伴有和不伴有血小板减少症的 HCC 的临床特征。

方法

对大量随机出现、经活检证实的 HCC 患者的基线临床数据进行检查,根据肿瘤大小进行分组,并进一步分为肿瘤大小三分位数,以观察表型模式。

结果

小肿瘤大小三分位数 I 患者的血小板计数最低。在每个大小三分位数内血小板较高的患者,胆红素和凝血酶原时间较低,γ-谷氨酰转肽酶(GGTP)和碱性磷酸酶(ALKP)水平较高。当比较具有相似血小板和胆红素水平的患者时,较大肿瘤和门静脉血栓形成患者的甲胎蛋白、GGTP 和 ALKP 显著增加。无血小板减少症的大肿瘤大小三分位数 III 患者的肿瘤较大,GGTP 和 ALKP 较高,胆红素水平较低,而血小板减少症患者的肿瘤较小。

结论

血小板减少症发生在较小肿瘤患者中的比例为 40.7%,而在较大肿瘤患者中仅为 11.3%。无论肿瘤大小如何,无血小板减少症的患者的 GGTP 和 ALKP 水平升高,胆红素水平降低,但在大肿瘤三分位数内的肿瘤也更大。

相似文献

1
Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.肝癌大小:血小板、γ-谷氨酰转肽酶和碱性磷酸酶。
Oncology. 2013;85(3):153-9. doi: 10.1159/000354416. Epub 2013 Aug 29.
2
Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.肝癌患者血小板减少与肿瘤大小的关系。
Oncology. 2012;83(6):339-45. doi: 10.1159/000342431. Epub 2012 Sep 18.
3
Low alpha-fetoprotein HCC and the role of GGTP.低甲胎蛋白肝癌与γ-谷氨酰转肽酶的作用
Int J Biol Markers. 2014 Dec 9;29(4):e395-402. doi: 10.5301/jbm.5000092.
4
Features of massive hepatocellular carcinomas.巨块型肝癌的特征。
Eur J Gastroenterol Hepatol. 2014 Jan;26(1):101-8. doi: 10.1097/MEG.0b013e3283644c49.
5
Significance of platelet and AFP levels and liver function parameters for HCC size and survival.血小板、甲胎蛋白水平及肝功能参数对肝癌大小和生存的意义。
Int J Biol Markers. 2014 Sep 30;29(3):e215-23. doi: 10.5301/jbm.5000064.
6
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.血浆胆红素异常与侵袭性肝细胞癌表型相关。
Semin Oncol. 2014 Apr;41(2):252-8. doi: 10.1053/j.seminoncol.2014.03.006. Epub 2014 Mar 6.
7
Hepatocellular Carcinoma Extrahepatic Metastasis in Relation to Tumor Size and Alkaline Phosphatase Levels.肝细胞癌肝外转移与肿瘤大小及碱性磷酸酶水平的关系
Oncology. 2016;90(3):136-42. doi: 10.1159/000443480. Epub 2016 Feb 12.
8
Small HCCs identified by screening.筛查发现的小 HCCs。
Dig Dis Sci. 2011 Oct;56(10):3078-85. doi: 10.1007/s10620-011-1687-x. Epub 2011 Apr 5.
9
Small hepatocellular carcinoma in Chinese patients.中国患者的小肝细胞癌
Hepatogastroenterology. 2011 Jul-Aug;58(109):1334-42. doi: 10.5754/hge11029.
10
Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.土耳其患者肝细胞癌侵袭性因素的特征
Oncology. 2018;94(2):116-124. doi: 10.1159/000484564. Epub 2017 Dec 6.

引用本文的文献

1
Platelets in Hepatocellular Carcinoma-From Pathogenesis to Targeted Therapy.肝细胞癌中的血小板——从发病机制到靶向治疗
Cancers (Basel). 2025 Jul 18;17(14):2391. doi: 10.3390/cancers17142391.
2
Predicting Resistance and Survival of HCC Patients Post-HAIC: Based on Shapley Additive exPlanations and Machine Learning.预测肝癌患者肝动脉灌注化疗术后的耐药性和生存率:基于夏普利值分解和机器学习
J Hepatocell Carcinoma. 2025 May 31;12:1111-1128. doi: 10.2147/JHC.S523806. eCollection 2025.
3
Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review.

本文引用的文献

1
Thrombocytosis and hepatocellular carcinoma.血小板增多与肝细胞癌。
Dig Dis Sci. 2013 Jun;58(6):1790-6. doi: 10.1007/s10620-012-2527-3. Epub 2013 Jan 12.
2
Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.肝癌患者血小板减少与肿瘤大小的关系。
Oncology. 2012;83(6):339-45. doi: 10.1159/000342431. Epub 2012 Sep 18.
3
Small hepatocellular carcinomas and thrombocytopenia.小肝癌和血小板减少症。
血小板减少症对肝细胞癌患者生存的影响:更新的荟萃分析和系统评价
Cancers (Basel). 2024 Mar 27;16(7):1293. doi: 10.3390/cancers16071293.
4
Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors.具有代谢危险因素的肝细胞癌的临床病理特征
J Hepatocell Carcinoma. 2023 Jun 5;10:833-846. doi: 10.2147/JHC.S412129. eCollection 2023.
5
Cadmium exposure modulates the gut-liver axis in an Alzheimer's disease mouse model.镉暴露在阿尔茨海默病小鼠模型中调节肠道-肝脏轴。
Commun Biol. 2021 Dec 15;4(1):1398. doi: 10.1038/s42003-021-02898-1.
6
Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma.肿瘤来源血小板 microRNAs 在肝细胞癌患者中的生物信息学分析。
Biosci Rep. 2021 Dec 22;41(12). doi: 10.1042/BSR20211420.
7
Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases.至死不渝——血小板在肝脏疾病中的多面角色。
Int J Mol Sci. 2021 Mar 18;22(6):3113. doi: 10.3390/ijms22063113.
8
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.大肝癌患者临床表型及相关生存情况的识别
Cancers (Basel). 2021 Feb 3;13(4):592. doi: 10.3390/cancers13040592.
9
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict tumor size and survival in HCC patients: Retrospective study.血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值可预测肝癌患者的肿瘤大小及生存情况:一项回顾性研究
Ann Med Surg (Lond). 2020 Sep 6;58:167-171. doi: 10.1016/j.amsu.2020.08.042. eCollection 2020 Oct.
10
Albumin-to-Alkaline Phosphatase Ratio Associates with Good Prognosis of Hepatitis B Virus-Positive HCC Patients.白蛋白与碱性磷酸酶比值与乙肝病毒阳性肝癌患者的良好预后相关。
Onco Targets Ther. 2020 Mar 20;13:2377-2384. doi: 10.2147/OTT.S242034. eCollection 2020.
Oncology. 2012;83(6):331-8. doi: 10.1159/000341533. Epub 2012 Sep 18.
4
Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.非肝硬化肝脏中肝细胞癌的肿瘤大小:切除术后预后的一个有争议的预测因素。
Eur J Surg Oncol. 2012 Dec;38(12):1189-96. doi: 10.1016/j.ejso.2012.07.112. Epub 2012 Aug 3.
5
Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.多结节性肝细胞癌肝切除术后短期生存的术前预测因素。
World J Gastroenterol. 2012 Jul 7;18(25):3272-81. doi: 10.3748/wjg.v18.i25.3272.
6
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.抗血小板治疗可预防乙型肝炎慢性模型小鼠的肝细胞癌并改善其生存。
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):E2165-72. doi: 10.1073/pnas.1209182109. Epub 2012 Jul 2.
7
Serotonin: a key molecule in acute and chronic liver injury!血清素:急性和慢性肝损伤中的关键分子!
Clin Res Hepatol Gastroenterol. 2012 Aug;36(4):319-22. doi: 10.1016/j.clinre.2012.05.005. Epub 2012 Jun 29.
8
Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction.通过未成熟血小板分数评估慢性丙型肝炎的血小板减少机制。
Int J Lab Hematol. 2012 Oct;34(5):525-32. doi: 10.1111/j.1751-553X.2012.01429.x. Epub 2012 Jun 18.
9
Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development.无环维甲酸靶向血小板衍生生长因子信号通路预防肝纤维化和肝癌发生。
Cancer Res. 2012 Sep 1;72(17):4459-71. doi: 10.1158/0008-5472.CAN-12-0028. Epub 2012 May 31.
10
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.日本非酒精性脂肪性肝病患者发生肝细胞癌的大规模长期随访研究。
Am J Gastroenterol. 2012 Feb;107(2):253-61. doi: 10.1038/ajg.2011.327. Epub 2011 Oct 18.